Biofrontera (BFRI) Non-Current Assets (2020 - 2025)
Biofrontera (BFRI) recorded quarterly Non-Current Assets of $10.5 million in Q4 2025, up 946.01% quarter-over-quarter from $1.0 million in Q3 2025, and up 648.11% on a YoY basis from $1.4 million in Q4 2024.
Biofrontera (BFRI) Non-Current Assets (2020 - 2025) Analysis & Trends
Biofrontera's Non-Current Assets history runs 6 years deep, the most recent figure standing at $10.5 million for Q4 2025.
- In Q4 2025, Non-Current Assets rose 648.11% year-over-year to $10.5 million; the TTM figure through Dec 2025 stood at $14.1 million (up 22.22% YoY), while the FY2025 annual figure was $10.5 million, up 648.11% from the prior year.
- Non-Current Assets was $10.5 million for Q4 2025 at Biofrontera, up from $1.0 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $10.5 million in Q4 2025 to a low of $1.0 million in Q3 2025.
- Historically, Non-Current Assets has averaged $4.7 million across 5 years, with a median of $4.7 million in 2023.
- Biggest YoY gain for Non-Current Assets was 648.11% in 2025; the steepest drop was 71.58% in 2025.
- A 5-year view of Non-Current Assets shows it stood at $6.8 million in 2021, then increased by 13.92% to $7.7 million in 2022, then sank by 37.28% to $4.9 million in 2023, then slumped by 71.16% to $1.4 million in 2024, then jumped by 648.11% to $10.5 million in 2025.
- The last three Non-Current Assets figures came in at $10.5 million (Q4 2025), $1.0 million (Q3 2025), and $1.3 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 26.33 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 8.68 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 3.84 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 2.47 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 9.64 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 2.90 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 1.22 Bn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.40 Bn |
| 10 | Biofrontera | 8.65 Mn | 2.24 Mn | 14.09 Mn | 10.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 10.48 Mn |
| Sep 30, 2025 | 1.00 Mn |
| Jun 30, 2025 | 1.33 Mn |
| Mar 31, 2025 | 1.26 Mn |
| Dec 31, 2024 | 1.40 Mn |
| Sep 30, 2024 | 1.59 Mn |
| Jun 30, 2024 | 4.10 Mn |
| Mar 31, 2024 | 4.42 Mn |
| Dec 31, 2023 | 4.86 Mn |
| Sep 30, 2023 | 4.49 Mn |
| Mar 31, 2023 | 4.74 Mn |
| Dec 31, 2022 | 7.74 Mn |
| Sep 30, 2022 | 6.57 Mn |
| Jun 30, 2022 | 6.65 Mn |
| Mar 31, 2022 | 6.67 Mn |
| Dec 31, 2021 | 6.80 Mn |
| Sep 30, 2021 | 5.22 Mn |
| Dec 31, 2020 | 4.56 Mn |